Clinical Trials Directory

Trials / Unknown

UnknownNCT05280795

Audit on Anemia Variation After Major Gynacological Surgery

an Audit on Postoperative Variations in Anemia Treatment After Major Gynecological Surgery

Status
Unknown
Phase
Study type
Observational
Enrollment
70 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
Female
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The study aims to increase our understanding of variability in adherence to anaemia management guidelines and to assess the impact of anaemia management in clinical care following major gynaecological surgery

Detailed description

Anemia affects nearly a quarter of the world and is common in surgical patients with a third of patients presenting with preoperative anemia and three quarters of patients discharged from hospital with anemia. The World Health Organization defines anemia as an insufficient circulating red cell mass, with haemoglobin (Hb) concentration of \< 130 g.l-1 for men and \< 120 g.l-1 for women . Perioperative anemia is associated with increased postoperative complications and delayed patient recovery leading to increased post-operative morbidity and mortality. Anaemia also leads to an increased use of allogeneic blood transfusions, which is an independent risk for poorer patient outcomes. Postoperative anemia can be due to blood loss at operation or secondary to the inflammatory process associated with surgery, which causes an increase in hepcidin production resulting in functional iron deficiency and reduced red cell production. In recent years, there has been a significant increase in the use of intravenous iron therapy for preoperative anemia in line with major international guidelines

Conditions

Timeline

Start date
2021-12-01
Primary completion
2022-06-30
Completion
2023-07-01
First posted
2022-03-15
Last updated
2022-03-15

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05280795. Inclusion in this directory is not an endorsement.